ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
202.93
+0.2900
0.14%
盤後:
203.02
0.0900
+0.04%
19:37 EDT
成交量:
228.63萬
成交額:
4.65億
市值:
102.78億
市盈率:
32.15
高:
205.31
開:
203.94
低:
202.75
收:
202.64
52周最高:
217.12
52周最低:
138.79
股本:
5,065.00萬
流通股本:
5,065.00萬
量比:
1.60
換手率:
4.51%
股息:
0.41
股息率:
0.20%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率:
24.54%
總資產收益率:
0.10%
市淨率:
1.26
市盈率(LYR):
-135.83
資料載入中...
總覽
公司
新聞
公告
概念
ETF&股票定投概念
+0.88%
碎股
+0.88%
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
松江奇蹟:一家中國藥企的「體系化出海」豪賭 | 未來企業調研行
华夏时报网
·
昨天
阿斯利康股價盤後跌超2%,因其三期臨床試驗結果令人失望。
智通财经
·
昨天
復星醫藥(600196.SH)子公司地舒單抗生物類似藥HLX14註冊申請獲受理
智通财经
·
09/11
又爆了!集體飆漲!中東,再傳重磅
同花顺
·
09/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/IBB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202.93,"timestamp":1789156800000,"preClose":202.64,"halted":0,"volume":2286306,"hourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"delay":0,"changeRate":0.0014311093564943766,"floatShares":50650000,"shares":50650000,"eps":6.311863,"marketStatus":"休市中","change":0.29,"latestTime":"09-11 16:00:00 EDT","open":203.94,"high":205.31,"low":202.75,"amount":465174036.47682,"amplitude":0.012633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202.64,"sharesOutstanding":49450000,"nav":202.867176,"aum":10356369334.8,"dividendRate":0.001997,"bidAskSpread":0.000338,"preHourTrading":{"tag":"盘前","latestPrice":204.63,"preClose":202.64,"latestTime":"09:25 EDT","volume":602,"amount":123106.38130000001,"timestamp":1789133112066,"change":1.99,"changeRate":0.00982,"amplitude":0.017917},"postHourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"volumeRatio":1.6013834487935477,"impliedVol":0.2368,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50650000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.6013834487935477,"shares":50650000,"dividePrice":0.4053,"high":205.31,"amplitude":0.012633,"preClose":202.64,"low":202.75,"week52Low":138.785,"pbRate":"1.26","psRate":"247.29","week52High":217.12,"institutionHeld":0,"latestPrice":202.93,"eps":6.311863,"divideRate":0.001997,"volume":2286306,"delay":0,"ttmEps":6.311863,"open":203.94,"prevYearClose":168.77,"prevWeekClose":211.92,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":213.81,"twentyDayClose":198.94,"sixtyDayClose":171.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666503466","title":"松江奇蹟:一家中國藥企的「體系化出海」豪賭 | 未來企業調研行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666503466","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666503466?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 12:14","pubTimestamp":1789186482,"startTime":"0","endTime":"0","summary":"编者按:9月的一天,《华夏时报》未来企业竞争力调研团队来到位于上海松江的复宏汉霖全球生产基地——中国生物制药版图上,一处正在悄悄改写规则的所在。这家中国生物药企拒绝只卖“青苗”,而是试图用生物类似药的现金流,搭建从临床、报批到商业化的全球闭环。但真正的考验在于:创新药管线能否在专利悬崖窗口期兑现为第二增长曲线。上海松江,文俊路618弄。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609123872706781.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609123872706781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","XPH","LU1992135472.HKD","IBB","LU1992135399.USD","LU2272731865.HKD","BK4135","BCG","LU2322448957.HKD","LU2322448791.USD","LU2473716301.USD","LU2272731782.SGD","IE00B5TLWC47.USD","PPH","BK4588","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%,因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2322448957.HKD","IBB","MRNY","PSCH","PJP","IYH","BK4588","FTXH","IDNA","LU1992135399.USD","FBT","TMED","IEIH","LU2272731600.USD","RXL","SYNB","WDNA","LU2272731865.HKD","RSPH","IBRN","SBIO","LFSC","LU1992135472.HKD","BK4585","LU2322448791.USD","BIB","BIOY","HELX","AZNH","CANC","LU2473716301.USD","IEHS","XBIX","PPH","MEDI","XPH","IE00B5TLWC47.USD","GNOM","BBP","MRNX","BME","LU2272731782.SGD","PBPH","PBE","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666235705","title":"復星醫藥(600196.SH)子公司地舒單抗生物類似藥HLX14註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666235705","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666235705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:44","pubTimestamp":1789119840,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药 发布公告,近日,公司控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司自主研发的地舒单抗生物类似药HLX14120mg/瓶规格的药品注册申请获国家药品监督管理局受理。此次申报适应症为其参照药安加维于中国境内已获批上市的所有适应症。据悉,HLX14为公司自主研发的地舒单抗生物类似药。截至公告日期,HLX14已分别于美国、欧盟、英国、加拿大获批上市。截至2026年8月,公司现阶段针对HLX14的累计研发投入约为3.52亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600196","PPH","BK0188","LU2272731865.HKD","BK4585","LU2473716301.USD","BK0187","BK0196","IE00B5TLWC47.USD","LU2272731782.SGD","XPH","BK1191","BK0175","BK0012","LU1992135399.USD","BK0096","02196","BK0183","BK0028","IBB","LU1992135472.HKD","BK0060","LU2322448957.HKD","LU2322448791.USD","BK1515","BK0239","BK4588","BK1593","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666528665","title":"又爆了!集體飆漲!中東,再傳重磅","url":"https://stock-news.laohu8.com/highlight/detail?id=2666528665","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666528665?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:37","pubTimestamp":1789011420,"startTime":"0","endTime":"0","summary":"中午好,在本周二大涨之后,能化板块又爆发了!周四早盘,原油期货主力合约一度涨近10%,纯苯、苯乙烯期货主力合约涨停。截至11:30收盘,原油期货主力合约涨幅有所收窄,纯苯期货主力合约涨 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260910/c679776426.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260910/c679776426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4566","LU2089984988.USD","LU2242646821.SGD","LU0058720904.USD","BK4139","IE0009355771.USD","LU1057294990.SGD","IBB","LU0122379950.USD","LU0889565916.HKD","AMGN","LU2112291526.USD","IE00BJT1NW94.SGD","PBE","LU0289739699.SGD","LU1983299246.USD","BK4581","BK4599","IE00B4R5TH58.HKD","LU0868494617.USD","IBBQ","LU2242652126.USD","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","BBH","IE0002141913.USD","TBXU","BK4585","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4533","IE00B2B36J28.USD","PJP","LU2468319806.SGD","SG9999001440.SGD","LU0320765992.SGD","BK4534","BIB","LU1023059063.AUD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBB\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF&股票定投概念","id":"package_us_concept_etf&gpdt","bkCode":"BK4585","changeRate":0.008842},{"market":"US","name":"碎股","id":"package_us_concept_sg","bkCode":"BK4588","changeRate":0.008827}]}}